CDC801

CAS No. 192819-27-5

CDC801( CDC-801 )

Catalog No. M26097 CAS No. 192819-27-5

CDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 226 In Stock
5MG 354 In Stock
10MG 505 In Stock
25MG 758 In Stock
50MG 995 In Stock
100MG 1349 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CDC801
  • Note
    Research use only, not for human use.
  • Brief Description
    CDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).
  • Description
    CDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).
  • In Vitro
    The more detailed information refer to the Compound 6b in the reference 1 (PMID:19256507).
  • In Vivo
    ——
  • Synonyms
    CDC-801
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    Potassium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    192819-27-5
  • Formula Weight
    408.454
  • Molecular Formula
    C23H24N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 16.67 mg/mL (40.81 mM)
  • SMILES
    COc1ccc(cc1OC1CCCC1)C(CC(N)=O)N1C(=O)c2ccccc2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hamilton KL,et al. DCEBIO stimulates Cl- secretion in the mouse jejunum. Am J Physiol Cell Physiol. 2006 Jan;290(1):C152-64.
molnova catalog
related products
  • GSK3145095

    GSK3145095 is an orally active inhibitor of RIPK1 with IC50 of 5 nM, with potential immunomodulatory activities and antineoplastic.

  • Adalimumab

    Adalimumab anti-TNF-alpha) is the first fully human recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha.

  • INH1

    INH1 is a cell-permeable Hec1 inhibitor that specifically disrupts the Hec1/Nek2 interaction.